Literature DB >> 16104127

Current medical management of gastroesophageal reflux disease.

G Richard Locke1.   

Abstract

Gastroesophageal reflux symptoms are common. Not everyone who has heartburn has reflux, as some people have functional heartburn in addition to many other symptoms. Alternatively, not everybody who has reflux has heartburn, and many symptoms are identified in which reflux may be playing a role. In most cases, the initial management strategy is empiric medical therapy. Often, this brings symptom relief, but when it does not, alternative diagnoses need to be considered. High-dose treatment trials and ambulatory pH monitoring have become more important than endoscopy in the diagnosis of reflux. Patients who have reflux typically require a chronic disease approach. This can be with medical therapy, surgery, or endoscopic approaches. GERD is associated with decreased quality of life; however, given the many helpful treatment options, no one should suffer from the symptoms of GERD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16104127     DOI: 10.1016/j.thorsurg.2005.04.004

Source DB:  PubMed          Journal:  Thorac Surg Clin            Impact factor:   1.750


  5 in total

Review 1.  Does chronic microaspiration cause idiopathic pulmonary fibrosis?

Authors:  Joyce S Lee; Harold R Collard; Ganesh Raghu; Matthew P Sweet; Steven R Hays; Guilherme M Campos; Jeffrey A Golden; Talmadge E King
Journal:  Am J Med       Date:  2010-04       Impact factor: 4.965

2.  The Role of Gastroesophageal Reflux and Microaspiration in Idiopathic Pulmonary Fibrosis.

Authors:  Joyce S Lee
Journal:  Clin Pulm Med       Date:  2014-03-01

3.  Self-reported sleep bruxism and nocturnal gastroesophageal reflux disease in patients with obstructive sleep apnea: relationship to gender and ethnicity.

Authors:  Sean Hesselbacher; Shyam Subramanian; Shweta Rao; Lata Casturi; Salim Surani
Journal:  Open Respir Med J       Date:  2014-10-22

Review 4.  Gastroesophageal Reflux Disease (GERD): Highlighting Diagnosis, Treatment, and Lifestyle Changes.

Authors:  Pratyaksh Chhabra; Nishikant Ingole
Journal:  Cureus       Date:  2022-08-29

5.  Pleiotropic effect of the proton pump inhibitor esomeprazole leading to suppression of lung inflammation and fibrosis.

Authors:  Yohannes T Ghebremariam; John P Cooke; William Gerhart; Carol Griego; Jeremy B Brower; Melanie Doyle-Eisele; Benjamin C Moeller; Qingtao Zhou; Lawrence Ho; Joao de Andrade; Ganesh Raghu; Leif Peterson; Andreana Rivera; Glenn D Rosen
Journal:  J Transl Med       Date:  2015-08-01       Impact factor: 5.531

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.